Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cataract AND hydroxymethylglutaryl-coa reductase inhibitors:

The pharmacology of statins. Sirtori CR et al. Pharmacol Res. (2014)

Non-cardiovascular effects associated with statins. Desai CS et al. BMJ. (2014)

Statins and cataract. Gaynes BI et al. JAMA Ophthalmol. (2014)

Search results

Items: 1 to 20 of 105

1.

Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis.

Yu S, Chu Y, Li G, Ren L, Zhang Q, Wu L.

J Am Heart Assoc. 2017 Mar 20;6(3). pii: e004180. doi: 10.1161/JAHA.116.004180. Review.

2.

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).

Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, Gupta M, Hegele RA, Ng D, Pearson GJ, Pope J, Tashakkor AY.

Can J Cardiol. 2016 Jul;32(7 Suppl):S35-65. doi: 10.1016/j.cjca.2016.01.003. Epub 2016 Jan 14. Review.

PMID:
27342697
3.

Statin use and risk of cataract: A nested case-control study within a healthcare database.

Casula M, Soranna D, Corrao G, Merlino L, Catapano AL, Tragni E.

Atherosclerosis. 2016 Aug;251:153-158. doi: 10.1016/j.atherosclerosis.2016.06.020. Epub 2016 Jun 11.

PMID:
27323228
4.

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E; HOPE-3 Investigators.

N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2.

5.

Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.

Mansi IA, English J, Zhang S, Mortensen EM, Halm EA.

Drug Saf. 2016 Jun;39(6):543-59. doi: 10.1007/s40264-016-0412-2.

PMID:
26979831
6.

An eye on nutrition: The role of vitamins, essential fatty acids, and antioxidants in age-related macular degeneration, dry eye syndrome, and cataract.

McCusker MM, Durrani K, Payette MJ, Suchecki J.

Clin Dermatol. 2016 Mar-Apr;34(2):276-85. doi: 10.1016/j.clindermatol.2015.11.009. Epub 2015 Nov 22.

PMID:
26903189
7.

Prevention of Cataract by Statins.

Kostis JB, Dobrzynski JM.

Am J Cardiol. 2016 Apr 1;117(7):1196. doi: 10.1016/j.amjcard.2016.01.001. Epub 2016 Jan 12. No abstract available.

PMID:
26851145
8.

Statin Use and Incident Cataract Surgery: A Case-Control Study.

Erie JC, Pueringer MR, Brue SM, Chamberlain AM, Hodge DO.

Ophthalmic Epidemiol. 2016;23(1):40-5. doi: 10.3109/09286586.2015.1077258. Epub 2016 Jan 14.

9.

Effects of Statins on the Development of Cataract-the Long Standing Debate.

Pourafkari L, Mahdavi-Fard A, Nader ND.

Am J Cardiol. 2016 Feb 1;117(3):489-90. doi: 10.1016/j.amjcard.2015.11.053. Epub 2015 Dec 8. No abstract available.

PMID:
26721658
10.

The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.

AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY.

Ophthalmology. 2016 Apr;123(4):916-7. doi: 10.1016/j.ophtha.2015.10.040. Epub 2015 Dec 11. No abstract available.

11.

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).

Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K.

Am J Cardiol. 2015 Dec 15;116(12):1840-4. doi: 10.1016/j.amjcard.2015.09.026. Epub 2015 Oct 3.

PMID:
26602073
12.

The impact of statins on biological characteristics of stem cells provides a novel explanation for their pleiotropic beneficial and adverse clinical effects.

Izadpanah R, Schächtele DJ, Pfnür AB, Lin D, Slakey DP, Kadowitz PJ, Alt EU.

Am J Physiol Cell Physiol. 2015 Oct 15;309(8):C522-31. doi: 10.1152/ajpcell.00406.2014. Epub 2015 Jul 29.

PMID:
26224580
13.

Statin Use and Risk of Cataract Response to Letter.

Kostis JB, Dobrzynski JM.

J Cardiovasc Pharmacol Ther. 2016 Mar;21(2):223. doi: 10.1177/1074248415591701. Epub 2015 Jun 17. No abstract available.

PMID:
26085336
14.

Response to Letter on Statin Use and Risk of Cataracts: Firm Conclusions Are Still Off.

Hippisley-Cox J.

J Cardiovasc Pharmacol Ther. 2016 Mar;21(2):222. doi: 10.1177/1074248415591699. Epub 2015 Jun 17. No abstract available.

PMID:
26085335
15.

Response to letter on "statins use and risk of cataracts: firm conclusions are still far off".

Kostis JB, Dobrzynski JM.

J Cardiovasc Pharmacol Ther. 2015 May;20(3):346-7. doi: 10.1177/1074248414560967. No abstract available.

PMID:
25877656
16.

Statins and cataracts: reverse causality?

Spence JD.

Can J Cardiol. 2015 May;31(5):691.e11. doi: 10.1016/j.cjca.2014.12.018. Epub 2014 Dec 19. No abstract available.

PMID:
25795104
17.

Statins and Cataracts--a visual insight.

Dobrzynski JM, Kostis JB.

Curr Atheroscler Rep. 2015;17(2):477. doi: 10.1007/s11883-014-0477-2. Review.

PMID:
25488134
18.

Statin use and risk for cataract: a nested case-control study of 2 populations in Canada and the United States.

Wise SJ, Nathoo NA, Etminan M, Mikelberg FS, Mancini GB.

Can J Cardiol. 2014 Dec;30(12):1613-9. doi: 10.1016/j.cjca.2014.08.020.

PMID:
25475465
19.

Doctor my eyes: a statin-cataract connection?

Gryn SE, Hegele RA.

Can J Cardiol. 2014 Dec;30(12):1508-10. doi: 10.1016/j.cjca.2014.08.019. No abstract available.

PMID:
25475455
20.

Statins use and risk of cataracts: firm conclusions are still far off.

Saint-Gerons DM, Honrubia Cde L, Montero D, González-Bermejo D, de Andrés-Trelles F, Catalá-López F.

J Cardiovasc Pharmacol Ther. 2015 May;20(3):344-5. doi: 10.1177/1074248414557890. Epub 2014 Dec 3. No abstract available.

PMID:
25472007

Supplemental Content

Loading ...
Support Center